All Stories

  1. Pathologies of oral and sinonasal mucosa following facial vascularized composite allotransplantation

    Article • Journal of Plastic Reconstructive & Aesthetic Surgery, July 2021, Elsevier

    Dr Francisco M Marty

  2. Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity

    Article • Med, April 2021, Elsevier

    Dr Francisco M Marty

  3. Racial Disproportionality in Covid Clinical Trials

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2020, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  4. New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19

    Article • Antimicrobial Agents and Chemotherapy, December 2020, ASM Journals

    Dr Francisco M Marty

  5. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2020, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  6. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19

    Article • JAMA, September 2020, American Medical Association (AMA)

    Dr Francisco M Marty

  7. Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series

    Article • Open Forum Infectious Diseases, September 2020, Oxford University Press (OUP)

    Dr Francisco M Marty

  8. Cell-Free DNA in Blood Reveals Significant Cell, Tissue and Organ Specific injury and Predicts COVID-19 Severity

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Dr Francisco M Marty

  9. How to Obtain a Nasopharyngeal Swab Specimen

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, July 2020, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  10. Safety and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and hepatitis B or hepatitis C infection

    Article • Lung Cancer, July 2020, Elsevier

    Dr Francisco M Marty

  11. Accelerated chronic skin changes without allograft vasculopathy: A 10-year outcome report after face transplantation

    Article • Surgery, June 2020, Elsevier

    Dr Francisco M Marty

  12. How to Obtain a Nasopharyngeal Swab Specimen

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2020, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  13. BK virus–specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation

    Article • Blood Advances, May 2020, American Society of Hematology

    Dr Francisco M Marty

  14. Cell-free DNA Profiling Informs Major Complications of Hematopoietic Cell Transplantation

    Article • April 2020, Cold Spring Harbor Laboratory Press

    Dr Francisco M Marty

  15. Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT

    Article • Blood, April 2020, American Society of Hematology

    Dr Francisco M Marty

  16. A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection

    Article • Nature Biomedical Engineering, April 2020, Springer Science + Business Media

    Dr Francisco M Marty

  17. Missing the Target

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2020, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  18. Defibrotide formulations contain (1→3)-β-D-glucan that could influence clinical diagnostic testing

    Article • Bone Marrow Transplantation, March 2020, Springer Science + Business Media

    Dr Francisco M Marty

  19. Missing the Target

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2020, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  20. Fulminant Acanthamoeba castellanii Encephalitis in an Ibrutinib-Treated Patient

    Article • Open Forum Infectious Diseases, January 2020, Oxford University Press (OUP)

    Dr Francisco M Marty

  21. Rapid assessment of nanomaterial homogeneity reveals crosswise structural gradients in zinc-oxide nanowire arrays

    Article • Nanoscale, January 2020, Royal Society of Chemistry

    Dr Francisco M Marty

  22. Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation

    Article • Arabian archaeology and epigraphy, December 2019, Wiley

    Dr Francisco M Marty

  23. A Phase II, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients

    Article • Clinical Infectious Diseases, December 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  24. A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of ...

    Article • Clinical Infectious Diseases, December 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  25. Use of triazoles for the treatment of invasive aspergillosis: A three‐year cohort analysis

    Article • Mycoses, October 2019, Wiley

    Dr Francisco M Marty

  26. Development of a Set of Lupus‐Specific Ambulatory Care Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study

    Article • Arthritis Care & Research, October 2019, Wiley

    Dr Francisco M Marty

  27. Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system

    Article • Medical Mycology, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  28. Case 31-2019: A 45-Year-Old Woman with Headache and Somnolence

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2019, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  29. Long-term Persistence of an Extensively Drug-Resistant Subclade of Globally Distributed Pseudomonas aeruginosa Clonal Complex 446 in an Academic Medical Center

    Article • Clinical Infectious Diseases, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  30. Reply to Singh

    Article • Clinical Infectious Diseases, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  31. Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals

    Article • Journal of Antimicrobial Chemotherapy, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  32. 1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis

    Article • Open Forum Infectious Diseases, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  33. 2453. Prolonged Local Epidemic of an XDR P. aeruginosa Subclade of High-Risk Clonal Complex 298

    Article • Open Forum Infectious Diseases, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  34. 2596. Invasive Fungal Disease in Patients with GATA2 Variant Hematologic Malignancy

    Article • Open Forum Infectious Diseases, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  35. 269. Epidemiology and Outcomes of Invasive Aspergillosis (IA) Among Pediatric Immunocompromised Patients: A 12-Year, Single-Center Experience

    Article • Open Forum Infectious Diseases, October 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  36. Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4+ and CD8+ T effector memory cells and increase of T regulatory cells

    Article • Clinical Immunology, October 2019, Elsevier

    Dr Francisco M Marty

  37. Invasive Fungal Carotiditis: A Rare Manifestation of Cranial Invasive Fungal Disease: Case Series and Systematic Review of the Literature

    Article • Open Forum Infectious Diseases, September 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  38. Herpes Zoster Subunit Vaccination for Renal Transplant Recipients

    Article • Clinical Infectious Diseases, August 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  39. Draft Genome Sequence of Pseudomonas aeruginosa Strain BWH047, a Sequence Type 235 Multidrug-Resistant Clinical Isolate Expressing High Levels of Colistin Resistance

    Article • Microbiology Resource Announcements, July 2019, ASM Journals

    Dr Francisco M Marty

  40. Reply to Aronson et al

    Article • Clinical Infectious Diseases, July 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  41. Five-Year Follow-up after Face Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 2019, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  42. A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation

    Article • Clinical Infectious Diseases, June 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  43. Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis?

    Article • Mycoses, April 2019, Wiley

    Dr Francisco M Marty

  44. Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation

    Article • Clinical Infectious Diseases, March 2019, Oxford University Press (OUP)

    Dr Francisco M Marty

  45. A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, February 2019, Elsevier

    Dr Francisco M Marty

  46. Authors’ Response

    Article • Journal of Thoracic Oncology, November 2018, Elsevier

    Dr Francisco M Marty

  47. 1140. GATA2 Mutations Are Frequently Identified Among Patients With Myeloid Malignancies Who Develop Invasive Aspergillosis

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  48. 1557. Acyclovir-Resistant (ACV-R) Herpes Simplex Virus (HSV) Disease in Patients with Hematologic Malignancies (HM) and Hematopoietic-Cell Transplant (HCT) Recipients

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  49. 1564. Lower Rates of Epstein–Barr Virus (EBV) Viremia in Pediatric Solid Organ Transplant (SOT) Recipients Who Received Valganciclovir Prophylaxis

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  50. 1576. Risk of Clinical Tuberculosis (TB) Among Patients with Latent TB Infection (LTBI) Who Undergo Allogeneic Hematopoietic-Cell Transplantation (HCT)

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  51. 1715. A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Trial to Examine the Effects of DAS181 in Immunocompromised (IC) Patients With Parainfluenza Virus (PIV) Lower Respiratory Tract Infection (LRTI) on Supplemental Oxygen (SO)

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  52. 1730. Outcomes of Patients With Detectable Cytomegalovirus (CMV) DNA at Randomization in the Double-blind, Placebo-Controlled Phase 3 Trial of Letermovir (LET) Prophylaxis for CMV-Seropositive Allogeneic Hematopoietic-Cell Transplantation (HCT) Recipients

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  53. 358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  54. 408. Invasive Fungal Petrositis and Carotiditis (IFPAC) Syndrome in Immunocompromised Hosts: An Unrecognized, Often Catastrophic Invasive Fungal Disease (IFD)

    Article • Open Forum Infectious Diseases, November 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  55. Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study

    Article • Clinical Infectious Diseases, October 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  56. Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation

    Article • Blood Advances, August 2018, American Society of Hematology

    Dr Francisco M Marty

  57. Isavuconazole for treatment of rare invasive fungal diseases

    Article • Mycoses, July 2018, Wiley

    Dr Francisco M Marty

  58. Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib

    Article • Leukemia & Lymphoma, July 2018, Taylor & Francis

    Dr Francisco M Marty

  59. Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection

    Article • Annals of Oncology, July 2018, Oxford University Press (OUP)

    Dr Francisco M Marty

  60. Case 5-2018: A Man with Confusion after Stem-Cell Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 2018, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  61. NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantation

    Article • Blood Advances, June 2018, American Society of Hematology

    Dr Francisco M Marty

  62. Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation

    Article • Blood Advances, June 2018, American Society of Hematology

    Dr Francisco M Marty

  63. Cytomegalovirus Infection Among Cord Blood Allogeneic Transplantation Recipients: Low Incidence of Cytomegalovirus Events without High-Dose Valacyclovir Prophylaxis

    Article • Biology of Blood and Marrow Transplantation, June 2018, Elsevier

    Dr Francisco M Marty

  64. Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation

    Article • PLOS One, May 2018, PLOS

    Dr Francisco M Marty

  65. Optical modeling of black silicon using an effective medium/multi-layer approach

    Article • Optics Express, May 2018, Optical Society of America (OSA)

    Dr Francisco M Marty, Professor Diaa Khalil

  66. Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial

    Article • Mycoses, April 2018, Wiley

    Dr Francisco M Marty

  67. Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species

    Article • Mycoses, April 2018, Wiley

    Dr Francisco M Marty

  68. Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients with Non-Small-Cell Lung Cancer

    Article • Journal of Thoracic Oncology, April 2018, Elsevier

    Dr Francisco M Marty

  69. Letermovir Prophylaxis for Cytomegalovirus

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2018, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  70. Risk of hepatitis B virus reactivation in patients treated with ibrutinib

    Article • Blood, February 2018, American Society of Hematology

    Dr Francisco M Marty

  71. Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation

    Article • Bone Marrow Transplantation, February 2018, Nature

    Dr Francisco M Marty

  72. Eponychial lesions following bilateral upper extremity vascular composite allotransplantation: a case report

    Article • Case Reports in Plastic Surgery and Hand Surgery, January 2018, Taylor & Francis

    Dr Francisco M Marty

  73. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2017, New England Journal of Medicine (NEJM/MMS)

    Dr David R Snydman, Dr Francisco M Marty

  74. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana‐Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline

    Article • The Oncologist, November 2017, Alphamed Press

    Dr Francisco M Marty

  75. Seasonal Variability Precipitating Hand Transplant Rejection?

    Article • Transplantation, October 2017, Wolters Kluwer Health

    Dr Francisco M Marty

  76. Serious Infection Rates Among Children With Systemic Lupus Erythematosus Enrolled in Medicaid

    Article • Arthritis Care & Research, September 2017, Wiley

    Dr Francisco M Marty

  77. Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantation

    Article • Oral Surgery Oral Medicine Oral Pathology and Oral Radiology, September 2017, Elsevier

    Dr Francisco M Marty

  78. Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy

    Article • The Journal of Infectious Diseases, June 2017, Oxford University Press (OUP)

    Dr Francisco M Marty

  79. Use of Multimodality Imaging in Diagnosing Invasive Fungal Diseases of the Heart

    Article • Circulation Cardiovascular Imaging, June 2017, Wolters Kluwer Health

    Dr Francisco M Marty

  80. dasatinib increases risk of cytomegalovirus reactivation when used after BMT

    Article • Clinical Infectious Diseases, April 2017, Oxford University Press (OUP)

    Dr Francisco M Marty

  81. mucositis had little impact on isavuconazole absorption

    Article • Antimicrobial Agents and Chemotherapy, March 2017, ASM Journals

    Dr Francisco M Marty

  82. Warm autoimmune hemolytic anemia can develop in patients with babesiosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2017, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  83. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana‐Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline

    Article • The Oncologist, February 2017, Alphamed Press

    Dr Francisco M Marty

  84. IV zanamivir was as effective as oral oseltamivir in patients with severe influenza

    Article • The Lancet Respiratory Medicine, February 2017, Elsevier

    Dr Francisco M Marty

  85. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications

    Article • Arthritis & Rheumatology, January 2017, Wiley

    Dr Francisco M Marty

  86. Face Transplantation in a Highly Sensitized Recipient

    Article • Military Medicine, October 2016, Oxford University Press (OUP)

    Dr Francisco M Marty

  87. Introducing the Wiley Transplant Peer Review Network

    Article • Arabian archaeology and epigraphy, August 2016, Wiley

    Dr Francisco M Marty

  88. The VITAL study: case control studies are hypothesis-generating – Authors' reply

    Article • The Lancet Infectious Diseases, August 2016, Elsevier

    Dr Francisco M Marty

  89. Introducing the Wiley Transplant Peer Review Network

    Article • Transplant International, July 2016, Wiley

    Dr Francisco M Marty

  90. Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study

    Article • Journal of Antimicrobial Chemotherapy, July 2016, Oxford University Press (OUP)

    Dr Francisco M Marty

  91. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

    Article • The Lancet Infectious Diseases, July 2016, Elsevier

    Dr Francisco M Marty, Souha Kanj

  92. Introducing The Wiley Transplant Peer Review Network

    Article • Artificial Organs, July 2016, Wiley

    Dr Francisco M Marty

  93. Face Transplantation in a Highly Sensitized Recipient

    Article • Military Medicine, May 2016, AMSUS

    Dr Francisco M Marty

  94. Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation

    Article • Transplant Infectious Disease, April 2016, Wiley

    Dr Francisco M Marty

  95. Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia

    Article • Diagnostic Microbiology and Infectious Disease, March 2016, Elsevier

    Dr Francisco M Marty

  96. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors

    Article • Biology of Blood and Marrow Transplantation, February 2016, Elsevier

    Dr Francisco M Marty

  97. Resolution of diarrhea in an immunocompromised patient with chronic norovirus gastroenteritis correlates with constitution of specific antibody blockade titer

    Article • Infection, January 2016, Springer Science + Business Media

    Dr Francisco M Marty

  98. In Vitro Volatile Metabolite Signatures of Common Pathogenic Fusarium Species

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    Dr Francisco M Marty

  99. Norovirus Infection in Transplantation: Prolonged and Morbid Diarrhea

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    Dr Francisco M Marty

  100. Scedosporium and lomentospora have unique in vitro VOC profiles

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    Dr Francisco M Marty

  101. Safety of Foscarnet (FOS) Treatment for Human Herpesviruses (HHV) in a Contemporary Cohort of Immunocompromised Patients

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    Dr Francisco M Marty

  102. Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia

    Article • PLOS One, November 2015, PLOS

    Dr Francisco M Marty

  103. Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors

    Article • Breast Cancer Research and Treatment, September 2015, Springer Science + Business Media

    Dr Francisco M Marty

  104. Cerebrospinal fluidCoccidioidesantigen testing in the diagnosis and management of central nervous system coccidioidomycosis

    Article • Mycoses, September 2015, Wiley

    Dr Francisco M Marty

  105. Invasive Fusariosis in the Voriconazole Era: Single-Center 13-Year Experience

    Article • Open Forum Infectious Diseases, July 2015, Oxford University Press (OUP)

    Dr Francisco M Marty

  106. Serious Infections Among Adult Medicaid Beneficiaries With Systemic Lupus Erythematosus and Lupus Nephritis

    Article • Arthritis & Rheumatology, May 2015, Wiley

    Dr Francisco M Marty

  107. Initial Experience of Dual Maintenance Immunosuppression With Steroid Withdrawal in Vascular Composite Tissue Allotransplantation

    Article • Arabian archaeology and epigraphy, March 2015, Wiley

    Dr Francisco M Marty

  108. BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation

    Article • Transplant Immunology, March 2015, Elsevier

    Dr Francisco M Marty

  109. Risk factors for invasive fungal disease in heart transplant recipients

    Article • The Journal of Heart and Lung Transplantation, February 2015, Elsevier

    Dr Francisco M Marty

  110. Decreasing Incidence of Candidemia Without Routine Systemic Antifungal Prophylaxis

    Article • Open Forum Infectious Diseases, January 2015, Oxford University Press (OUP)

    Dr Francisco M Marty

  111. Utility of Sentinel Flaps in Assessing Facial Allograft Rejection

    Article • Plastic & Reconstructive Surgery, January 2015, Wolters Kluwer Health

    Dr Francisco M Marty

  112. Cystic Fibrosis

    Article • January 2015, Elsevier

    Dr Francisco M Marty

  113. A Breath Fungal Secondary Metabolite Signature to Diagnose Invasive Aspergillosis

    Article • Clinical Infectious Diseases, October 2014, Oxford University Press (OUP)

    Dr Francisco M Marty

  114. Reply to "Insufficient Demonstration of Long-Term Stability of Aspergillus Galactomannan"

    Article • Journal of Clinical Microbiology, October 2014, ASM Journals

    Dr Francisco M Marty

  115. A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients

    Article • Blood, September 2014, American Society of Hematology

    Dr Francisco M Marty

  116. Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation

    Article • Annals of Internal Medicine, September 2014, American College of Physicians

    Dr Francisco M Marty

  117. Serologic Response to Hepatitis B Vaccination Among Lung Transplantation Candidates

    Article • Transplantation, September 2014, Wolters Kluwer Health

    Dr Francisco M Marty

  118. Triple opportunistic pulmonary cavitary disease after cord blood transplantation

    Article • Transplant Infectious Disease, August 2014, Wiley

    Dr Francisco M Marty

  119. Clinical characteristics and outcomes of clostridial bacteraemia in cancer patients

    Article • Clinical Microbiology and Infection, August 2014, Elsevier

    Dr Francisco M Marty

  120. The polyomavirus puzzle: is host immune response beneficial in controlling BK virus after adult hematopoietic cell transplantion?

    Article • Transplant Infectious Disease, May 2014, Wiley

    Dr Francisco M Marty

  121. The Management of Antibody-Mediated Rejection in the First Presensitized Recipient of a Full-Face Allotransplant

    Article • Arabian archaeology and epigraphy, May 2014, Wiley

    Dr Francisco M Marty

  122. Green Herring Syndrome: Bacterial Infection in Patients With Mucormycosis Cavitary Lung Disease

    Article • Open Forum Infectious Diseases, April 2014, Oxford University Press (OUP)

    Dr Francisco M Marty

  123. Long-Term Stability at -20 C of Aspergillus Galactomannan in Serum and Bronchoalveolar Lavage Specimens

    Article • Journal of Clinical Microbiology, April 2014, ASM Journals

    Dr Francisco M Marty

  124. BK Virus Disease after Allogeneic Stem Cell Transplantation: A Cohort Analysis

    Article • Biology of Blood and Marrow Transplantation, April 2014, Elsevier

    Dr Francisco M Marty

  125. Cefepime vs Other Antibacterial Agents for the Treatment of Enterobacter Species Bacteremia

    Article • Clinical Infectious Diseases, March 2014, Oxford University Press (OUP)

    Dr Francisco M Marty

  126. Adjunctive management of central line-associated bloodstream infections with 70% ethanol-lock therapy

    Article • Journal of Antimicrobial Chemotherapy, February 2014, Oxford University Press (OUP)

    Dr Francisco M Marty

  127. Live Attenuated Varicella-Zoster Vaccine in Hematopoietic Stem Cell Transplantation Recipients

    Article • Biology of Blood and Marrow Transplantation, February 2014, Elsevier

    Dr Francisco M Marty

  128. disseminated mucormycosis treated successfully with isavuconazole

    Article • Journal of Clinical Microbiology, January 2014, ASM Journals

    Dr Francisco M Marty

  129. DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation

    Article • Transplant Infectious Disease, January 2014, Wiley

    Dr Francisco M Marty

  130. Cost analysis of dental services needed before hematopoietic cell transplantation

    Article • Oral Surgery Oral Medicine Oral Pathology and Oral Radiology, January 2014, Elsevier

    Dr Francisco M Marty

  131. Sociodemographics and epidemiology of serious infections requiring hospitalization among adults with systemic lupus erythematosus and lupus nephritis, 2000 to 2006

    Article • Arthritis Research & Therapy, January 2014, Springer Science + Business Media

    Dr Francisco M Marty

  132. Ask, Don't Tell — Mobile Phones to Improve HIV Care

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2013, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  133. Bradyrhizobium enterica in Cord Colitis Syndrome

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2013, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  134. Incidence and risk factors for herpes zoster following heart transplantation

    Article • Transplant Infectious Disease, October 2013, Wiley

    Dr Francisco M Marty

  135. CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2013, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  136. Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study

    Article • The Journal of Infectious Diseases, August 2013, Oxford University Press (OUP)

    Dr Francisco M Marty

  137. Sequence-Based Discovery ofBradyrhizobium entericain Cord Colitis Syndrome

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2013, New England Journal of Medicine (NEJM/MMS)

    Dr Aleksandar D Kostic, Dr Francisco M Marty

  138. Postoperative Antibacterial Prophylaxis for the Prevention of Infectious Complications Associated With Tube Thoracostomy in Patients Undergoing Elective General Thoracic Surgery

    Article • JAMA Surgery, May 2013, American Medical Association (AMA)

    Dr Francisco M Marty

  139. Development and Evaluation of a Calibrator Material for Nucleic Acid-Based Assays for Diagnosing Aspergillosis

    Article • Journal of Clinical Microbiology, April 2013, ASM Journals

    Dr Francisco M Marty

  140. Fatal adenovirus encephalomyeloradiculitis in an umbilical cord stem cell transplant recipient

    Article • Neurology, April 2013, Wolters Kluwer Health

    Dr Francisco M Marty

  141. Vascularized composite tissue allotransplantation - state of the art

    Article • Clinical Transplantation, April 2013, Wiley

    Dr Francisco M Marty

  142. Neutropenia Associated With Prolonged Daptomycin Use: Table 1.

    Article • Clinical Infectious Diseases, January 2013, Oxford University Press (OUP)

    Dr Francisco M Marty

  143. Infections Following Facial Composite Tissue Allotransplantation-Single Center Experience and Review of the Literature

    Article • Arabian archaeology and epigraphy, December 2012, Wiley

    Dr Francisco M Marty

  144. Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis

    Article • Transplant Infectious Disease, December 2012, Wiley

    Dr Francisco M Marty

  145. Cord-Blood Hematopoietic Stem Cell Transplant Confers an Increased Risk for Human Herpesvirus-6-Associated Acute Limbic Encephalitis: A Cohort Analysis

    Article • Biology of Blood and Marrow Transplantation, November 2012, Elsevier

    Dr Francisco M Marty

  146. InvasiveMycoleptodiscusfungal cellulitis and myositis

    Article • Medical Mycology, October 2012, Oxford University Press (OUP)

    Dr Francisco M Marty

  147. Safety of Posaconazole and Sirolimus Coadministration in Allogeneic Hematopoietic Stem Cell Transplants

    Article • Biology of Blood and Marrow Transplantation, September 2012, Elsevier

    Dr Francisco M Marty

  148. A Targeted Peritransplant Antifungal Strategy for the Prevention of Invasive Fungal Disease After Lung Transplantation

    Article • Transplantation, August 2012, Wolters Kluwer Health

    Dr Francisco M Marty

  149. Respiratory Virus Detection in Immunocompromised Patients with FilmArray Respiratory Panel Compared to Conventional Methods

    Article • Journal of Clinical Microbiology, July 2012, ASM Journals

    Dr Francisco M Marty

  150. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study

    Article • Transplant Infectious Disease, June 2012, Wiley

    Dr Francisco M Marty

  151. Infectious Disease Board Review Questions

    Article • June 2012, Oxford University Press (OUP)

    Dr Francisco M Marty

  152. Post-diagnostic kinetics of the (1 → 3)-β-d-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia

    Article • Clinical Microbiology and Infection, May 2012, Elsevier

    Dr Francisco M Marty

  153. Three Patients with Full Facial Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 2012, New England Journal of Medicine (NEJM/MMS)

    Dr. Dennis P Orgill, Dr Francisco M Marty

  154. Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients

    Article • Transplant Infectious Disease, February 2012, Wiley

    Dr Francisco M Marty

  155. Serum Galactomannan and (1->3)- -D-Glucan Assays for Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia

    Article • Journal of Clinical Microbiology, December 2011, ASM Journals

    Dr Francisco M Marty

  156. Maribavir and human cytomegalovirus—what happened in the clinical trials and why might the drug have failed?

    Article • Current Opinion in Virology, December 2011, Elsevier

    Dr Francisco M Marty

  157. How Do We Manage Oral Infections in Allogeneic Stem Cell Transplantation and Other Severely Immunocompromised Patients?

    Article • Oral and Maxillofacial Surgery Clinics of North America, November 2011, Elsevier

    Dr Francisco M Marty

  158. Cord Colitis Syndrome in Cord-Blood Stem-Cell Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2011, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  159. Treatment of Parainfluenza 3 Infection With DAS181 in a Patient After Allogeneic Stem Cell Transplantation

    Article • Clinical Infectious Diseases, August 2011, Oxford University Press (OUP)

    Dr Francisco M Marty

  160. Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis, 2001 to 2009

    Article • Antimicrobial Agents and Chemotherapy, August 2011, ASM Journals

    Dr Francisco M Marty

  161. Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease

    Article • Mycoses, June 2011, Wiley

    Dr Francisco M Marty

  162. Pandemic H1N1 Influenza Infection in Adult Transplant Recipients

    Article • Transplantation, June 2011, Wolters Kluwer Health

    Dr Francisco M Marty, Prof. Sarman Singh

  163. Timeline of Infections after Hematopoietic Stem Cell Transplant

    Article • May 2011, Wiley

    Dr Francisco M Marty

  164. Immune Reconstitution after Myeloablative Stem Cell Transplant

    Article • May 2011, Wiley

    Dr Francisco M Marty

  165. Elevated Serum Beta-d-Glucan Levels in Immunocompromised Children with Clinical Suspicion for Pneumocystis jirovecii Pneumonia

    Article • Clinical and Vaccine Immunology, May 2011, ASM Journals

    Dr Francisco M Marty

  166. Molecular Methods To Improve Diagnosis and Identification of Mucormycosis: Fig. 1.

    Article • Journal of Clinical Microbiology, April 2011, ASM Journals

    Dr Francisco M Marty

  167. HIV-1 and 2009 H1N1 Influenza A in Adults

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2011, Wolters Kluwer Health

    Dr Francisco M Marty, Prof. Sarman Singh

  168. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

    Article • The Lancet Infectious Diseases, April 2011, Elsevier

    Dr Francisco M Marty

  169. Seroprotective Titers against 2009 H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

    Article • Biology of Blood and Marrow Transplantation, March 2011, Elsevier

    Dr Francisco M Marty

  170. Cerebral phaeohyphomycosis caused by Bipolaris spicifera after heart transplantation

    Article • Transplant Infectious Disease, February 2011, Wiley

    Dr Francisco M Marty

  171. Infectious Complications Associated with Immunomodulating Biologic Agents

    Article • Hematology/Oncology Clinics of North America, February 2011, Elsevier

    Dr Francisco M Marty

  172. Gordonia bronchialis Bacteremia and Pleural Infection: Case Report and Review of the Literature

    Article • Journal of Clinical Microbiology, January 2011, ASM Journals

    Dr Francisco M Marty

  173. Invasive Fungal Disease after Remote Inoculation in Transplant Recipients

    Article • Clinical Infectious Diseases, January 2011, Oxford University Press (OUP)

    Dr Francisco M Marty

  174. Xenotropic Murine Leukemia Virus–Related Virus Prevalence in Patients with Chronic Fatigue Syndrome or Chronic Immunomodulatory Conditions

    Article • The Journal of Infectious Diseases, November 2010, Oxford University Press (OUP)

    Dr Francisco M Marty

  175. Fonsecaea monophoracerebral phaeohyphomycosis: case report of successful surgical excision and voriconazole treatment and review

    Article • Medical Mycology, August 2010, Oxford University Press (OUP)

    Dr Francisco M Marty

  176. Aspergillus DNA contamination in blood collection tubes

    Article • Diagnostic Microbiology and Infectious Disease, August 2010, Elsevier

    Dr Francisco M Marty

  177. Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients

    Article • Transplant Infectious Disease, July 2010, Wiley

    Dr Francisco M Marty

  178. Invasive fungal disease in patients treated for newly diagnosed acute leukemia

    Article • American Journal of Hematology, July 2010, Wiley

    Dr Francisco M Marty

  179. Infectious Complications Associated with Immunomodulating Biologic Agents

    Article • Infectious Disease Clinics of North America, June 2010, Elsevier

    Dr Francisco M Marty

  180. Disseminated dermatophytosis in a patient with hereditary hemochromatosis and hepatic cirrhosis: case report and review of the literature

    Article • Medical Mycology, May 2010, Oxford University Press (OUP)

    Dr Francisco M Marty, Duane Hospenthal

  181. Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis

    Article • Journal of Clinical Microbiology, April 2010, ASM Journals

    Dr Francisco M Marty

  182. Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?

    Article • Journal of Antimicrobial Chemotherapy, April 2010, Oxford University Press (OUP)

    Dr Francisco M Marty

  183. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: A retrospective, observational, sequential cohort analysis

    Article • Clinical Therapeutics, April 2010, Elsevier

    Dr Francisco M Marty

  184. Infectious Granulomatous Dermatitis Associated With Rothia mucilaginosa Bacteremia: A Case Report

    Article • American Journal of Dermatopathology, April 2010, Wolters Kluwer Health

    Dr Francisco M Marty

  185. Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis

    Article • Journal of Clinical Microbiology, February 2010, ASM Journals

    Dr Francisco M Marty

  186. Transplant infectious disease as a subspecialty: does outlining how we train define who we are?

    Article • Transplant Infectious Disease, December 2009, Wiley

    Dr Francisco M Marty

  187. Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease

    Article • Clinical Infectious Diseases, December 2009, Oxford University Press (OUP)

    Dr Francisco M Marty

  188. Diagnostic Efficacy and Safety of Computed Tomography-Guided Transthoracic Needle Biopsy in Patients with Hematologic Malignancies

    Article • Academic Radiology, November 2009, Elsevier

    Dr Francisco M Marty

  189. DisseminatedGeotrichum candiduminfection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the literature

    Article • Transplant Infectious Disease, October 2009, Wiley

    Dr Francisco M Marty

  190. Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, September 2009, Elsevier

    Dr Francisco M Marty

  191. Strongyloideshyperinfection syndrome and transplantation: a preventable, frequently fatal infection

    Article • Transplant Infectious Disease, April 2009, Wiley

    Dr Francisco M Marty

  192. Positively false

    Article • Journal of Hospital Medicine, March 2009, Frontline Medical Communications, Inc.

    Dr Francisco M Marty

  193. Role of (1→3)-β-D-glucan in the diagnosis of invasive aspergillosis

    Article • Medical Mycology, January 2009, Oxford University Press (OUP)

    Dr Francisco M Marty

  194. Human herpesvirus 6 encephalitis

    Article • Current Infectious Disease Reports, July 2008, Springer Science + Business Media

    Dr Francisco M Marty

  195. Recovery of Herbaspirillum Species from Persons with Cystic Fibrosis

    Article • Journal of Clinical Microbiology, June 2008, ASM Journals

    Professor Peter A Vandamme, Dr Francisco M Marty

  196. POST-TRANSPLANT ACUTE LIMBIC ENCEPHALITIS: CLINICAL FEATURES AND RELATIONSHIP TO HHV6

    Article • Neurology, February 2008, Wolters Kluwer Health

    Dr Francisco M Marty

  197. Persistent and Relapsing Babesiosis in Immunocompromised Patients

    Article • Clinical Infectious Diseases, February 2008, Oxford University Press (OUP)

    Dr Francisco M Marty

  198. chapter reviewing key infectious diseases after hematopoietic-cell transplantation

    Article • January 2008, Springer Science + Business Media

    Dr Francisco M Marty

  199. Management of Oral Infections in Cancer Patients

    Article • Dental Clinics of North America, January 2008, Elsevier

    Dr Francisco M Marty

  200. Posaconazole for Invasive Aspergillosis?

    Article • Clinical Infectious Diseases, September 2007, Oxford University Press (OUP)

    Dr Francisco M Marty

  201. Post-transplant acute limbic encephalitis: Clinical features and relationship to HHV6

    Article • Neurology, July 2007, Wolters Kluwer Health

    Dr Francisco M Marty

  202. (1→3)β-d-Glucan Assay Positivity in Patients with Pneumocystis (carinii) jiroveci Pneumonia

    Article • Annals of Internal Medicine, July 2007, American College of Physicians

    Dr Francisco M Marty

  203. Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study

    Article • Transplant Infectious Disease, June 2007, Wiley

    Dr Francisco M Marty

  204. Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis

    Article • Blood, March 2007, American Society of Hematology

    Dr Francisco M Marty

  205. Torsades de pointes associated with voriconazole use

    Article • Transplant Infectious Disease, March 2007, Wiley

    Dr Francisco M Marty

  206. Reactivity of (1→3)-β-d-Glucan Assay with Commonly Used Intravenous Antimicrobials

    Article • Antimicrobial Agents and Chemotherapy, October 2006, ASM Journals

    Dr Francisco M Marty

  207. The persistent challenges of bacterial infections in the transplant recipient

    Article • Transplant Infectious Disease, September 2006, Wiley

    Dr Francisco M Marty

  208. Treatment of Cavitary Pulmonary Zygomycosis With Surgical Resection and Posaconazole

    Article • The Annals of Thoracic Surgery, July 2006, Elsevier

    Dr Francisco M Marty

  209. Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders

    Article • Clinical Infectious Diseases, July 2006, Oxford University Press (OUP)

    Dr Francisco M Marty

  210. Transmission of Lymphocytic Choriomeningitis Virus by Organ Transplantation

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2006, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  211. Voriconazole and Sirolimus Coadministration after Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, May 2006, Elsevier

    Dr Francisco M Marty

  212. Emergence of a Clinical Daptomycin-Resistant Staphylococcus aureus Isolate during Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis

    Article • Journal of Clinical Microbiology, February 2006, ASM Journals

    Dr Francisco M Marty

  213. The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy

    Article • Transplant International, January 2006, Wiley

    Dr Francisco M Marty

  214. Lyme Meningoradiculitis and Myositis after Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Clinical Infectious Diseases, December 2005, Oxford University Press (OUP)

    Dr Francisco M Marty

  215. Treatment of Human Disseminated Strongyloidiasis with a Parenteral Veterinary Formulation of Ivermectin

    Article • Clinical Infectious Diseases, July 2005, Oxford University Press (OUP)

    Dr Francisco M Marty

  216. Myiasis Due toDermatobia hominis(Human Botfly)

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 2005, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  217. Caspofungin versus Liposomal Amphotericin B for Empirical Therapy

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2005, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  218. Principles of antimicrobial therapy in the transplant patient

    Article • Transplant Infectious Disease, September 2004, Wiley

    Dr Francisco M Marty

  219. Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell Transplants

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 2004, New England Journal of Medicine (NEJM/MMS)

    Dr Francisco M Marty

  220. Disseminated Trichosporonosis Caused by Trichosporon loubieri

    Article • Journal of Clinical Microbiology, November 2003, ASM Journals

    Dr Francisco M Marty

  221. Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

    Article • Blood, October 2003, American Society of Hematology

    Dr Francisco M Marty

  222. Antifungal use in HIV infection

    Article • Expert Opinion on Pharmacotherapy, February 2002, Informa Healthcare

    Dr Francisco M Marty

  223. patient with neurosyphilis presented with temporal lobe syndrome

    Article • Clinical Infectious Diseases, April 2001, Oxford University Press (OUP)

    Dr Francisco M Marty